Genomics

Illumina Welcomes Activist Board Member and Appoints Former FDA Chief as New Chair

1 month ago

Illumina, a prominent biotechnology company known for its DNA sequencing technology, has made significant changes to its board of directors as it seeks to navigate the evolving landscape of the genomic industry. In a bold move, the company has appointed an activist investor to its board, aiming to enhance its strategic direction and shareholder engagement. Additionally, Illumina has named a former chief of the U.S. Food and Drug Administration (FDA) as the new chair of the board, a decision that underlines the company's commitment to regulatory excellence and innovation.

Illumina Faces Turmoil: February 2025 Sparks its Worst Performance in Over Two Decades

2 months ago

Illumina Inc., a prominent name in the biotechnology industry, has encountered severe financial headwinds, marking February 2025 as the company's most challenging month in 23 years. As global economic conditions shift, the imposition of tariffs by China and diminishing investment capital have combined to create a perfect storm that has severely impacted Illumina's stock, culminating in a staggering decline of nearly 30%.

Chinese Competitors Leverage Illumina's Blacklisting to Attract Clients

2 months ago

In a significant development within the biotechnology sector, Chinese rivals are strategically capitalizing on the recent blacklisting of Illumina, a leading player in the genomics industry. This move has opened the door for these competitors to enhance their market presence and appeal to potential clients who are currently reevaluating their partnerships and technology sourcing.

New Variants of Mpox Heighten Concerns Over Spread in Africa, Warns CDC

6 months ago

Recent findings from the Africa Centers for Disease Control and Prevention (Africa CDC) indicate a troubling rise in mutations of the mpox virus, also known as monkeypox, which is significantly increasing concerns regarding its transmission throughout the continent. This alarming update comes as various African countries continue to grapple with the potential resurgence of the virus, which had largely been under control in recent months.